SHAANXI THE RIVER PHARMACEUTICAL CO LTD

Overview

SHAANXI THE RIVER PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering ACETYLCYSTEINE; CYTISINICLINE; LEUPROLIDE ACETATE; SEMAGLUTIDE.

API / Drug Master Files

SHAANXI THE RIVER PHARMACEUTICAL CO LTD holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ACETYLCYSTEINEActive2025-04-16
• SEMAGLUTIDEActive2025-02-24
• LEUPROLIDE ACETATEActive2024-09-30
• CYTISINICLINEActive2023-10-11

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHAANXI THE RIVER PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.